| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 1e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |